CARA - Cara Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5408.91M
Enterprise Value 3338.54M
Trailing P/E N/A
Forward P/E 1-6.74
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)448.86
Price/Book (mrq)4.13
Enterprise Value/Revenue 3371.61
Enterprise Value/EBITDA 6-5.14

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-7,379.69%

Management Effectiveness

Return on Assets (ttm)-44.65%
Return on Equity (ttm)-77.15%

Income Statement

Revenue (ttm)911k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)86k
EBITDA -65.84M
Net Income Avi to Common (ttm)-65.92M
Diluted EPS (ttm)-2.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.98M
Total Cash Per Share (mrq)3.16
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.57
Book Value Per Share (mrq)3.04

Cash Flow Statement

Operating Cash Flow (ttm)-56.6M
Levered Free Cash Flow (ttm)-32.36M

Trading Information

Stock Price History

Beta 2.65
52-Week Change 350.11%
S&P500 52-Week Change 316.72%
52 Week High 328.50
52 Week Low 38.62
50-Day Moving Average 312.46
200-Day Moving Average 314.40

Share Statistics

Avg Vol (3 month) 3774.83k
Avg Vol (10 day) 3776.27k
Shares Outstanding 532.61M
Float 27.44M
% Held by Insiders 14.91%
% Held by Institutions 160.85%
Shares Short 3720.72k
Short Ratio 323.01
Short % of Float 30.00%
Shares Short (prior month) 3591.87k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A